MedPath

Analysis of third-line H. pylori eradication therapy with sitafloxaci

Not Applicable
Conditions
Patients with H. pylori eradication failure after first- and second-line therapy
Registration Number
JPRN-UMIN000001902
Lead Sponsor
Department of Gastroenterology, University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

penicillin or quinolone allergy rabeprazole allergy severe liver or renal dysfunction pregnancy or suckling cases with unsuitable determined by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eradication rate of H. pylori infection by the regimen including sitafloxacin
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath